Trial
NCT05821374
Deucravacitinib in PG
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
Bristol-Myers Squibb
Condition
Pyoderma Gangrenosum
Intervention
Deucravacitinib
Why stopped
Issues with funding and IND holder
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-27